Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 5 | 0 | €683.50 | €759.34 | 11.095% |
| Biogen Inc. | 45 | 2 | 5 | 1 | €202.10 | €294.01 | 45.478% |
| Vertex Pharmaceuticals Inc. | 41 | 2 | 5 | 0 | €372.60 | €382.71 | 2.712% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.60 | €228.30 | 61.229% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 6 | 1 | €889.20 | €957.22 | 7.650% |
| Pfizer Inc. | 31 | 4 | 3 | 1 | €25.85 | €41.10 | 59.006% |
| Johnson & Johnson | 31 | 1 | 2 | 0 | €138.72 | €196.36 | 41.551% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €118.60 | €124.92 | 5.331% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.00 | €83.81 | 37.401% |
| Amgen Inc. | 23 | 0 | 4 | 0 | €289.20 | €298.90 | 3.353% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 7 | 0 | €64.00 | €79.43 | 24.109% |
| Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €102.25 | €184.92 | 80.851% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.05 | €28.06 | 86.426% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.28 | €200.06 | 28.837% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €152.18 | €174.43 | 14.623% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.62 | €102.62 | 33.932% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.68 | €25.20 | 98.839% |
| Icon plc | 18 | 0 | 4 | 0 | €280.90 | €319.67 | 13.802% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.42 | €11.05 | 223.053% |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €114.50 | €130.00 | 13.537% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 4 | 0 | €39.80 | €84.74 | 112.925% |